36C24523Q0151.docx

SUBJECT*

Urine and Oral Toxicology Testing Kits Base Plus Four Option Year IDIQ Contract

GENERAL INFORMATION

VA Maryland Health Care System Zachary Altner Contracting Officer (90C) P.O. Box 1000, Bldg. 101b Room 2 Perry Point MD 21902

POINT OF CONTACT*

Zachary Altner

PLACE OF PERFORMANCE

10 North Greene Street

Baltimore Maryland

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

EMAIL DESCRIPTION

DESCRIPTION

See attached RFQ 36C24523Q0151

This is a Small Business Set Aside.

Responses are due by 12/13/2022 at 12:00 P.M. EST.

Combined Synopsis/Solicitation Notice Combined Synopsis/Solicitation Notice Email responses to Zachary.Altner@va.gov

Combined Synopsis/Solicitation Notice

Description This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, “Streamlined Procedures for Evaluation and Solicitation for Commercial Items,” as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation document will not be issued.

This solicitation is issued as an RFQ. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2021-05.

Note to CO: Obtain the most recent Federal Acquisition Circular (FAC) from ACQUISITION.GOV Federal Acquisition Regulation

This solicitation is set-aside for Small Business Set-Aside

The associated North American Industrial Classification System (NAICS) code for this procurement is 325413.

The FSC/PSC is 6550.

The Pathology & Laboratory Medicine Service requires an Indefinite Delivery Indefinite Quantity (IDIQ) base plus option year contract to provide urine and oral toxicology testing for the VA Baltimore Medical Center. This contract will cover the following requirements for up to a five-year total term:

Urine Drug Testing

· EIA presumptive screening:

· Confirmation (definitive) Screening by LC/MS/MS or GC/MS:

· A panel test of any number of EIA drugs can be developed

Oral Fluid Drug Testing

· 10 Panel EIA presumptive screen (with Fentanyl):

· Collection devices unit purchased in a bundle of ten

· Confirmation (definitive) Screening by LC/MS/MS:

Courier Service

· Monday through Friday – vendor will pick up on a regular schedule from VA-Baltimore Laboratory

Turnaround time for results:

· EIA within 24 hours of pick-up

· Confirmations (Definitive): within 72 hours of pick-up

Access to online portal through username and password

Results can be sent by email notification

Estimated annual usages are based off the historical usage at the VA Baltimore Medical Center. Final actual usages for this contract are subject to change as the facilities testing needs shift.

Additionally, please see the Statement of Work below for additional details and requirements.

Please provide unit pricing for each of the above listed testing kits. Invoices will be calculated for the total amounts of testing conducted each month and a monthly invoice will be submitted and paid out to the vendor.

All interested companies shall provide brand name or equal quotations for the following:

Supplies/Services

Urine Toxicology Testing (Primarily Fentanyl with Miscellaneous Testing as Required). EIA Presumptive Screening/Confirmatory LC/MS/MS

Fentanyl urine EIA $___ per unit: Estimated Monthly Quantity 617 Tests.

Auto Reflex all positives to GC/MS or LC/MS/MS at $____ per drug or drug class: Estimated Monthly Quantity 84 Tests.

11 Panel Oral Fluid Drug Screen $____ per screen Amp, Benzo, Bup, Coc, Fent, Methadone, Methamp, Opiates, Oxy, PCP, THC: Estimated Monthly Quantity 35 Tests.

Auto Reflex all positives to LC/MS/MS at $____ per drug or drug class: Estimated Monthly Quantity 75 Tests.

Oral fluid collection devices are $____ per device

*All option years will contain the above three-line items

Statement of Work

The Pathology & Laboratory Medicine Services requires Urine and Oral Toxicology Testing Kits for the VA Baltimore Medical Center. We are seeking to establish an indefinite delivery indefinite quantity contract to provide these toxicology testing kits for a period of five total years.

The total amounts required of these toxicology testing kits are currently in flux year to year as the Medical Centers get back to a more normalized testing environment post-covid.

The following are monthly estimated quantities for each of the testing kits:

Urine Drug Testing:

EIA presumptive screening: 617 Monthly Tests Confirmation (definitive) Screening by LC/MS/MS or GC/MS: 84 Monthly Tests A panel test of any number of EIA drugs can be developed

Oral Fluid Drug Testing:

10 Panel EIA presumptive screen (with Fentanyl): 35 Monthly Tests Confirmation (definitive) Screening by LC/MS/MS: 75 Monthly Tests

Collection Devices:

These numbers are only estimates and further modifications may be done to increase or decrease the quantities required.

The period of performance for the base and contract option years are as follows:

Base Year: 12/16/2022 to 12/15/2023 Option Year 1: 12/16/2023 to 12/15/2024 Option Year 2: 12/16/2024 to 12/15/2025 Option Year 3: 12/16/2025 to 12/15/2026 Option Year 4: 12/16/2026 to 12/15/2027 Place of Performance/Place of Delivery

10 N. Green Street Baltimore, MD

The full text of FAR provisions or clauses may be accessed electronically at http://acquisition.gov/comp/far/index.html.

The following solicitation provisions apply to this acquisition:

1. FAR 52.212-1, “Instructions to Offerors–Commercial Items”

2. FAR 52.212-3, “Offerors Representations and Certifications–Commercial Items”

Offerors must complete annual representations and certifications electronically via the System for Award Management (SAM) website located at https://www.sam.gov/portal in accordance with FAR 52.212-3, “Offerors Representations and Certifications–Commercial Items.” If paragraph (j) of the provision is applicable, a written submission is required.

The following contract clauses apply to this acquisition:

· FAR 52.212-4, “Contract Terms and Conditions–Commercial Items” 03/11/2021

· FAR 52.212-5, “Contract Terms and Conditions Required to Implement Statutes or Executive Orders” 03/11/2021

The following subparagraphs of FAR 52.212-5 are applicable:

All quoters shall submit the following: Please see below information in accordance to FAR 52.212-1(b).

Award will be based upon a comparative evaluation of quotes in accordance with the Simplified Acquisition Procedures of FAR 13. Comparative evaluation is the side by side pairwise comparison of quotes based on factors resulting in a Contracting Officer decision for the quote most favorable to the Government.

The following are the decision factors:

· Vendor’s ability to begin shipments on 12/16/2022.

· The vendor should be able to provide all required Toxicology Testing Materials requested within this solicitation.

· Ability to provide a quick turnaround delivery time of testing kits. The medical center conducts these tests as needed so it is imperative to have these quick lead times on delivery to get the testing kits quickly after an order has been placed.

· The Vendor must have the ability to meet the quantity of testing kits as well as the volume of orders that will be placed against this contract. As this is an IDIQ contract exact volumes and quantities are unknown and expected to be fluid from month to month.

The award will be made to the response most advantageous to the Government.

Responses should contain your best terms, conditions and shipping costs.

(b) Submission of offers. Submit signed and dated offers to the office specified in this solicitation at or before the exact time specified in this solicitation. Offers may be submitted on the SF 1449, letterhead stationery, or as otherwise specified in the solicitation. As a minimum, offers must show—

(1) The solicitation number;

(2) The time specified in the solicitation for receipt of offers;

(3) The name, address, and telephone number of the offeror;

(4) A technical description of the items being offered in sufficient detail to evaluate compliance with the requirements in the solicitation. This may include product literature, or other documents, if necessary;

(5) Terms of any express warranty;

(6) Price and any discount terms;

(7) "Remit to" address, if different than mailing address;

(8) A completed copy of the representations and certifications at FAR 52.212-3 (see FAR 52.212-3(b) for those representations and certifications that the offeror shall complete electronically);

(9) Acknowledgment of Solicitation Amendments;

(10) Past performance information, when included as an evaluation factor, to include recent and relevant contracts for the same or similar items and other references (including contract numbers, points of contact with telephone numbers and other relevant information); and

(11) If the offer is not submitted on the SF 1449, include a statement specifying the extent of agreement with all terms, conditions, and provisions included in the solicitation. Offers that fail to furnish required representations or information or reject the terms and conditions of the solicitation may be excluded from consideration.

(c) Period for acceptance of offers. The offeror agrees to hold the prices in its offer firm for 30 calendar days from the date specified for receipt of offers, unless another time period is specified in an addendum to the solicitation.

(d) Product samples. When required by the solicitation, product samples shall be submitted at or prior to the time specified for receipt of offers. Unless otherwise specified in this solicitation, these samples shall be submitted at no expense to the Government, and returned at the sender’s request and expense, unless they are destroyed during pre-award testing.

(e) Multiple offers. Offerors are encouraged to submit multiple offers presenting alternative terms and conditions, including alternative line items (provided that the alternative line items are consistent with subpart 4.10 of the Federal Acquisition Regulation), or alternative commercial items for satisfying the requirements of this solicitation. Each offer submitted will be evaluated separately.

To facilitate the award process, all quotes must include a statement regarding the terms and conditions herein as follows:

"The terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion, or addition."

OR

"The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:"

Quoters shall list exception(s) and rationale for the exception(s), if any.

Submission of your response shall be received not later than 12/13/2022 at 12:00 P.M. EST. to Zachary.Altner@va.gov.

Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f).

(f) Late submissions, modifications, revisions, and withdrawals of offers.

(1) Offerors are responsible for submitting offers, and any modifications, revisions, or withdrawals, so as to reach the Government office designated in the solicitation by the time specified in the solicitation. If no time is specified in the solicitation, the time for receipt is 4:30 p.m., local time, for the designated Government office on the date that offers, or revisions are due.

Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to the Point of Contact listed below.

Point of Contact Rebecca Gobble, Contracting Officer, 410-642-2411 x.26534, Rebecca.Gobble@va.gov Zachary Altner, Contract Specialist, 410-642-2411 x25262, Zachary.Altner@va.gov VHAPM Part 813.106 SAP: Soliciting Competition & Evaluation of Quotations SOP Page 11 of 11 Original Date: 10/12/17 Revision 04 Date: 06/10/20